22 März 2016 Jahr - FDA requires a new boxed warning about the serious risks of misuse and abuse, which can lead to addiction, overdose and death. The FDA also requires several additional safety labeling changes across all prescription opioid products to include additional information on the risk of these medications.
Zugefügt zum Band der Zeit:
Datum:
22 März 2016 Jahr
Jetzt
~ 9 years and 7 months ago